Trial Profile
A Multicenter, Randomized, Double-Blind, Four-Week, Bilateral Study of the Safety and Efficacy of Two Concentrations of AN2728 Ointment Administered Once or Twice a Day in Adolescents With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2017
Price :
$35
*
At a glance
- Drugs Crisaborole (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Anacor Pharmaceuticals
- 25 Mar 2014 Results presented at the 72nd Annual Meeting of the American Academy of Dermatology.
- 28 Feb 2014 New trial record
- 27 Feb 2014 Anacor Pharmaceuticals originally reported the results of this study on 21 March 2013, according to a company media release.